UPMC Presbyterian is a 900-bed non-profit research and academic hospital located in the Oakland neighborhood of Pittsburgh, Pennsylvania, providing tertiary care for the Western Pennsylvania region and beyond. It comprises the Presbyterian campus of the combined UPMC Presbyterian Shadyside hospital entity.

There are 900 beds in UPMC Presbyterian Hospital.

During the past decade, UPMC Presbyterian Hospital conducted 126 clinical trials. In the 10-year time frame, 126 clinical trials started and 76 clinical trials were completed, i.e. on average, 60.3% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 46 clinical trials were completed. i.e. 131.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UPMC Presbyterian Hospital" #1 sponsor was "University of Pittsburgh" with 27 trials, followed by "National Cancer Institute (NCI)" with 25 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "SWOG Cancer Research Network" with 12 trials sponsored and "Medtronic Cardiac Rhythm and Heart Failure" with 12 trials sponsored. Other sponsors include 131 different institutions and companies that sponsored additional 100 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Presbyterian Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 35 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 11 trials as a collaborator, "Medical University of South Carolina" with 10 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator and "Canadian Cancer Trials Group" with 6 trials as a collaborator. Other collaborators include 125 different institutions and companies that were collaborators in the rest 110 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Presbyterian Hospital" are "Coronary Artery Disease" (12 trials), "Pulmonary Arterial Hypertension" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Heart Failure" (7 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials). Many other conditions were trialed in "UPMC Presbyterian Hospital" in a lesser frequency.

Most popular intervention types in "UPMC Presbyterian Hospital" are "Drug" (108 trials), "Other" (66 trials), "Device" (55 trials), "Biological" (30 trials) and "Procedure" (27 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (31 trials), "Placebo" (20 trials), "Cisplatin" (10 trials), "Quality-of-Life Assessment" (10 trials) and "Docetaxel" (9 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Presbyterian Hospital" are 211 trials for "All" genders, 10 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 92 active trials in "UPMC Presbyterian Hospital". 5 are not yet recruiting, 37 are recruiting, 46 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 86 completed trials in UPMC Presbyterian Hospital, 2 suspended trials, and 29 terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Presbyterian Hospital, 9 "Phase 1" clinical trials were conducted, 52 "Phase 2" clinical trials and 75 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 60 trials that are defined as “Not Applicable".